2014
DOI: 10.1093/ndt/gfu364
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis

Abstract: EVs derived from EPCs exert a protective effect in Thy1.1 glomerulonephritis by inhibition of antibody- and complement-mediated injury of mesangial cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
58
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 73 publications
(64 citation statements)
references
References 37 publications
5
58
1
Order By: Relevance
“…EVs demonstrated a protective effect in experimental Thy1.1 glomerulonephritis in rats induced by complement-mediated mesangial injury (Cantaluppi et al, 2015). Indeed, after iv injection, EVs derived from endothelial progenitor cells localize within injured glomeruli and inhibit mesangial cell activation, leucocyte infiltration and apoptosis.…”
Section: Therapeutic Application Of Evs In Renal Pathologymentioning
confidence: 99%
See 1 more Smart Citation
“…EVs demonstrated a protective effect in experimental Thy1.1 glomerulonephritis in rats induced by complement-mediated mesangial injury (Cantaluppi et al, 2015). Indeed, after iv injection, EVs derived from endothelial progenitor cells localize within injured glomeruli and inhibit mesangial cell activation, leucocyte infiltration and apoptosis.…”
Section: Therapeutic Application Of Evs In Renal Pathologymentioning
confidence: 99%
“…Moreover, EV treatment decreases proteinuria, increases serum complement hemolytic activity, ameliorates renal function, preserves podocyte marker synaptopodin and endothelial antigen RECA-1. EVs' beneficial effect on mesangial cells was due to the inhibition of anti-Thy1.1 antibody/complement-induced apoptosis and C5b-9/C3 mesangial cell deposition (Cantaluppi et al, 2015). …”
Section: Therapeutic Application Of Evs In Renal Pathologymentioning
confidence: 99%
“…In this study, total microRNA depletion by Dicer knockdown and RNase digestion diminished the protective effects of EPC–derived microvesicles. In another study by Cantaluppi et al [24], EVs were injected intravenously to rats with anti-Thy1.1 glomerulonephritis and these EVs were shown to have protective effects by amelioration of mesangial injury caused by antibody and complement-mediated mechanisms.…”
Section: Basic Concepts About Epcsmentioning
confidence: 99%
“…This systemic condition is defined by accumulation of various products of nitrogen metabolism, such as urea. Intravenous injection of the isolated nanovesicles to mesangiolytic glomerulonephritis induced rats leads to the formation of vesicles around the injured renal region specifically the glomeruli (Cantaluppi et al, 2015). There have been various studies on investigation of aforementioned nanostructures for this purpose.…”
Section: Therapeutic Effects Of Exosomes On Kidney Injurymentioning
confidence: 99%
“…These cells are known to induce tissue repair by the paracrine mechanism including the release of nanovesicles. Intravenous injection of the isolated nanovesicles to mesangiolytic glomerulonephritis induced rats leads to the formation of vesicles around the injured renal region specifically the glomeruli (Cantaluppi et al, 2015). They inhibited mesangial cell activation, leucocyte infiltration, and apoptosis, in addition to decreasing proteinuria and increasing serum complement hemolytic activity.…”
Section: Therapeutic Effects Of Exosomes On Kidney Injurymentioning
confidence: 99%